Specialists for Fibrolamellar hepatocellular carcinoma

31 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Charles M Rice
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Gadi Lalazar
Rare Disease / Clinical Research
The Rockefeller University
NEW YORK, NY
QC-verified 2
Zachary J Brown
Rare Disease / Clinical Research
The Ohio State University Wexner Medical Center
QC-verified 2
Timothy M Pawlik, M.D
Rare Disease / Clinical Research
The Ohio State University Wexner Medical Center
COLUMBUS, OH
QC-verified 2
Bassem Shebl
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Tova M Finkelstein
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Denise Ng, DDS
Rare Disease / Clinical Research
The Rockefeller University
SAN FRANCISCO, CA
QC-verified 2
Ype P de Jong
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Yasuyuki Shigematsu
Rare Disease / Clinical Research
Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)
QC-verified 1
Kazuhito Tanaka
Rare Disease / Clinical Research
Kumamoto University Hospital
QC-verified 1
Sanford M Simon
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 4
Philip Coffino, MD
Rare Disease / Clinical Research
The Rockefeller University
SAN FRANCISCO, CA
QC-verified 3
David Requena
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Mahsa Shirani
Rare Disease / Clinical Research
The Rockefeller University
QC-verified 2
Michael S Torbenson, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
QC-verified 2
Mark Yarchoan, MD, M.D
Rare Disease / Clinical Research
Johns Hopkins Medical Institution
BALTIMORE, MD
PI×2
Marina Baretti, MD, MD
Rare Disease / Clinical Research
SKCCC • Johns Hopkins Medical Institution
BALTIMORE, MD
PI×2
Ghassan Abou-Alfa, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×5
Gregory M Tiao, MD
Rare Disease / Clinical Research
Children's Oncology Group
PALO ALTO, CA
PI×1 7
Michael V Ortiz
Rare Disease / Clinical Research
Pediatric Early Phase Clinical Trial Network
PI×2 18
Aung Naing
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2
Jessica Gartrell, MD, MD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
MEMPHIS, TN
PI×2
Allison O'Neill, MD
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
PI×3 1
Camila MV Moniz, Doctor
Rare Disease / Clinical Research
Oncologist
SAN ANTONIO, TX
PI×1
Tim F Greten, M.D., M.D
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×10
Sunyoung Lee
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2 1095
Salih, Prof. Dr.
Rare Disease / Clinical Research
CCU Translational Immunology
PI×1
Ken Ren, PhD
Rare Disease / Clinical Research
CASI Pharmaceuticals, Inc.
NEW YORK, NY
PI×1
Sandrine Faivre
Rare Disease / Clinical Research
Hopital Beaujon
PI×4 1
jean-charles nault, Pr
Rare Disease / Clinical Research
Federation Francophone de Cancerologie Digestive
PI×1
Ghassan Abou-Alfa, MD, MBA, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×1

More about Fibrolamellar hepatocellular carcinoma